CTOs on the Move

Parexel

www.parexel.com

 
PAREXEL International Corporation is the world`s leading innovator of biopharmaceutical services. We simplify our clients` journey of transforming scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services. PAREXEL develops breakthrough innovations and solutions by leveraging its comprehensive therapeutic, technical and functional expertise, in more than 100 countries around the world.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.parexel.com
  • 195 West Street
    Waltham, MA USA 02451
  • Phone: 781.487.9900

Executives

Name Title Contact Details
Anthony Sofo
Director, IT Security Profile
Gary Swartz
Senior Director, Client Technology Partner Profile
Anthony Carrillo
Associate Director, Information Security, Americas Profile
Gavin Nichols
Executive Vice President of Informatics and Information Technology Profile

Jobs

Senior Director HR Operations

Parexel Waltham, Massachusetts
Job Description :
1. Overall Accountability
Lead the North and South America HR Operations team. Develop the performance capabilities of client groups and of the HR Operations Team in order to increase PAREXEL competitive advantage. Drive quality and process improvement in all HR Operations services. Drive and deliver operational execution ...

Similar Companies

Neomorph

Neomorph is a venture backed biotechnology company based in San Diego, California.

Spotlight Therapeutics

Spotlight Therapeutics is a venture funded early-stage biotechnology company with a mission to develop a new class of therapeutics by enabling direct in vivo gene editing. Founded by Alex Marson (UCSF), Jacob Corn (UC Berkeley), and Patrick Hsu (Salk Institute) in December of 2017, Spotlight is building its core technology platform to achieve precise in vivo gene editing in targeted cell populations. With a therapeutic focus centered on oncology, our engineered nucleases edit the genes in targeted disease organs thereby inactivating or altering the gene product. We are hiring rapidly to build out our cutting-edge research and development team. This team is responsible for preclinical development ranging from protein engineering, gene editing to immuno-oncology and in vivo safety studies. Join us and work on the next generation of gene editing therapeutics in a fast-paced and exciting environment.

Rgenta Therapeutics

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs

Visionary Products Inc

Visionary Products Inc is a Draper, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ONL Therapeutics

ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal disease and conditions.​